Free Submission Public Relations & NewsPR-inside.com
 
DeutschEnglish

Get the latest news
with our RSS feed
rss feed
Add to My Yahoo!
More information
Business

Zacks Analyst Interview Highlights: Hershey Foods, Dean Foods, Anheuser-Busch, UST and Altria


Print article Print article
Refer this article Refer to a friend
© Business Wire 2008
2008-10-08 12:07:02 -

- Zacks.com releases the latest Analyst Interview. Today's interview is with senior equities analyst Steven Ralston, who discusses Hershey Foods (NYSE: HSY), Dean Foods (NYSE: DF), Anheuser-Busch (NYSE: BUD), UST (NYSE: UST) and Altria (NYSE: MO).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: at.zacks.com/?id=2678.

The problem of tainted milk from China seems to be more widespread than originally thought. Do you see this having a direct affect on companies in your coverage?

Milk is a significant raw material for two of my companies: Hershey Foods (NYSE: HSY) and Dean Foods (NYSE: DF). On September 29th, Hershey issued a statement that the company has never purchased milk from China. Dean Foods owns it own fluid milk operations in the U.S., and may even benefit as consumers move to soy-based products, which the company provides.

Any Sells, and/or general issues to be wary of?

Over the last two years, I have been a table-pounding buyer of Anheuser-Busch (NYSE: BUD) under $50. With the final friendly offer of $70 per share from InBev on July 14th, I finally downgraded the rating to a Sell.

On September 8th, UST (NYSE: UST) received a buyout offer of $69.50 per share in cash from Altria (NYSE: MO), at which time the rating was lowered to a Sell. With the sub-prime crisis spreading to the credit markets, both transactions are in jeopardy of being completed due to financing issues. During declining markets, some investors flock to stocks involved in buyouts as a safe haven. Be wary of these transactions for they may not be completed.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks Profit from the Pros e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today by visiting at.zacks.com/?id=2679.

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at at.zacks.com/?id=4581.

Visit www.zacks.com/performance for information about the performance numbers displayed in this press release.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

Zacks.com
Mark Vickery
Zacks Web Content Editor
312-265-9380
Visit: www.zacks.com


Disclaimer: (c) 2007 Business Wire. All of the news releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.


Terms & Conditions | About us | Contact PR-inside.com